Partnership for Safe Medicines statement on FDA authorization of Colorado’s Section 804 Importation Program

PSM released the following statement today regarding Colorado’s misguided Canadian Drug Importation program:

The Partnership for Safe Medicines strongly opposes Canadian drug importation programs across the country, and FDA’s decision today to authorize Colorado’s Section 804 Importation Program marks a disappointing development for Colorado patients and taxpayers.

“Colorado is now poised to repeat Florida’s failed attempt to implement Canadian drug importation,” said PSM Executive Director Shabbir Imber Safdar. “Since beginning their program in 2019, Florida has spent $132 million and still not imported a single unit of medicine, proving that these bulk importation programs are not reducing drug costs for Americans.

Colorado’s program will not result in lower cost medicines for its residents but could drain funds from the state’s coffers, ultimately doing a disservice to all Coloradans. It’s a losing proposition at a time when consumers deserve better.”

To learn more about problems related to foreign drug importation and see the poor track record of the Florida program, see PSM’s Canadian drug importation page and these key resources:

● Read the approval letter from FDA To Colorado
● February 2026 update on importation patient safety dangers
● Why Canadian drug importation is unworkable.
● What Canadians have said about Americans importing their medicine supply from Canada.
● Canada’s detailed objections to Canadian drug importation